MARKET

NNVC

NNVC

Nanoviricides
AMEX
1.260
-0.090
-6.67%
After Hours: 1.265 +0.005 +0.40% 16:09 03/01 EST
OPEN
1.355
PREV CLOSE
1.350
HIGH
1.370
LOW
1.210
VOLUME
25.27K
TURNOVER
0
52 WEEK HIGH
2.000
52 WEEK LOW
1.000
MARKET CAP
14.84M
P/E (TTM)
-1.5742
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at NNVC last week (0219-0223)?
Weekly Report · 6d ago
Weekly Report: what happened at NNVC last week (0212-0216)?
Weekly Report · 02/19 12:34
NanoViricides Restructures Agreements to Alleviate Financial Stress
TipRanks · 02/16 22:03
EF Hutton Reiterates Buy on Nanoviricides, Maintains $6.5 Price Target
Benzinga · 02/16 12:14
Nanoviricides Q2 EPS $(0.18) Down From $(0.15) YoY; As Of December 31, 2023, We Had Cash And Cash Equivalent Current Assets Balance Of Approximately $5.31M. Additional Agreements Have Resulted In A Further Approximately $2.5M Available Cash
Benzinga · 02/15 11:44
NanoViricides GAAP EPS of -$0.18
Seeking Alpha · 02/15 11:38
Weekly Report: what happened at NNVC last week (0205-0209)?
Weekly Report · 02/12 12:19
Weekly Report: what happened at NNVC last week (0129-0202)?
Weekly Report · 02/05 12:32
More
About NNVC
NanoViricides, Inc. is a development stage company, which is creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. Its lead drug candidate is NV-CoV-2 (API NV-387) for the treatment of COVID-19 disease caused by SARS-CoV-2 coronavirus. Its other advanced candidate is NV-HHV-1 for the treatment of Shingles. NV-CoV-2 is its nanoviricide drug candidate for COVID-19 containing the nanoviricide API, NV-387. NV-CoV-2-R is its other drug candidate for COVID-19, which is made up of NV-387 with remdesivir encapsulated within its polymeric micelles. It has developed both of its own drug candidates, NV-CoV-2 and NV-CoV-2-R independently. It is also developing drugs against a number of viral diseases, including RSV, oral and genital Herpes, viral diseases of the eye, including EKC and herpes keratitis, H1N1 swine flu, H5N1 bird flu and others.

Webull offers NanoViricides Inc stock information, including AMEX: NNVC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NNVC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NNVC stock methods without spending real money on the virtual paper trading platform.